Freed, I.M.; Kasi, A.; Fateru, O.; Hu, M.; Gonzalez, P.; Weatherington, N.; Pathak, H.; Hyter, S.; Sun, W.; Al-Rajabi, R.;
et al. Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Cells 2023, 12, 2266.
https://doi.org/10.3390/cells12182266
AMA Style
Freed IM, Kasi A, Fateru O, Hu M, Gonzalez P, Weatherington N, Pathak H, Hyter S, Sun W, Al-Rajabi R,
et al. Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Cells. 2023; 12(18):2266.
https://doi.org/10.3390/cells12182266
Chicago/Turabian Style
Freed, Ian M., Anup Kasi, Oluwadamilola Fateru, Mengjia Hu, Phasin Gonzalez, Nyla Weatherington, Harsh Pathak, Stephen Hyter, Weijing Sun, Raed Al-Rajabi,
and et al. 2023. "Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients" Cells 12, no. 18: 2266.
https://doi.org/10.3390/cells12182266
APA Style
Freed, I. M., Kasi, A., Fateru, O., Hu, M., Gonzalez, P., Weatherington, N., Pathak, H., Hyter, S., Sun, W., Al-Rajabi, R., Baranda, J., Hupert, M. L., Chalise, P., Godwin, A. K., A. Witek, M., & Soper, S. A.
(2023). Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Cells, 12(18), 2266.
https://doi.org/10.3390/cells12182266